Lucid Diligence Brief: Neuralink’s 2026 high-volume BCI plan
Lucid Diligence Brief: Neuralink’s 2026 high-volume BCI plan Professional…
Lucid Diligence Brief: Sinopia Biosciences receives NIGMS grant for LEADS platform
Lucid Diligence Brief: Sinopia Biosciences receives NIGMS grant for LEADS…
Artificial Intelligence in Healthcare 2025 Review: From Pilot Tools to Operating Infrastructure
2025 marked the year artificial intelligence stopped behaving like an…
Lucid Diligence Brief: Neurable raises $35M Series A to scale brain-signal AI
Lucid Diligence Brief: Neurable raises $35M Series A to scale brain-signal AI…
Lucid Diligence Brief: Truemed $34m Series A to scale payment integration platform
Lucid Diligence Brief: Truemed $34m Series A to scale payment integration…
Lucid Diligence Brief: Paradigm to acquire Flatiron’s Clinical Research Business
Lucid Diligence Brief: Paradigm to acquire Flatiron’s Clinical Research…
Lucid Diligence Brief: Sword Health partners with Greece on AI health "front door"
Lucid Diligence Brief: Sword Health partners with Greece on AI health "front…
Lucid Diligence Brief: Function Health raises $298M Series B at $2.5B
Lucid Diligence Brief: Function Health raises $298M Series B at $2.5B…
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home Alzheimer’s blood collection
Lucid Diligence Brief: Neurogen Biomarking and Tasso partnership for at-home…
Lucid Diligence Brief: WellBeam $10M Series A
Lucid Diligence Brief: WellBeam $10M Series A Professional audiences only. Not…
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG platform
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG…
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast…